181 related articles for article (PubMed ID: 22179686)
1. Establishment and characterization of two 5-fluorouracil-resistant hepatocellular carcinoma cell lines.
Uchibori K; Kasamatsu A; Sunaga M; Yokota S; Sakurada T; Kobayashi E; Yoshikawa M; Uzawa K; Ueda S; Tanzawa H; Sato N
Int J Oncol; 2012 Apr; 40(4):1005-10. PubMed ID: 22179686
[TBL] [Abstract][Full Text] [Related]
2. Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial to mesenchymal transition changes.
Harada K; Ferdous T; Ueyama Y
Int J Oncol; 2014 Apr; 44(4):1302-8. PubMed ID: 24452635
[TBL] [Abstract][Full Text] [Related]
3. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.
Gu W; Fang FF; Li B; Cheng BB; Ling CQ
Asian Pac J Cancer Prev; 2012; 13(9):4807-14. PubMed ID: 23167424
[TBL] [Abstract][Full Text] [Related]
4. Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway.
Jiao J; Hong S; Zhang J; Ma L; Sun Y; Zhang D; Shen B; Zhu C
Cancer Lett; 2012 Jul; 320(1):96-103. PubMed ID: 22313545
[TBL] [Abstract][Full Text] [Related]
5. Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma.
Kataoka J; Shiraha H; Horiguchi S; Sawahara H; Uchida D; Nagahara T; Iwamuro M; Morimoto H; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Takaki A; Nouso K; Yagi T; Yamamoto K; Okada H
Oncol Rep; 2016 May; 35(5):2576-82. PubMed ID: 26985715
[TBL] [Abstract][Full Text] [Related]
6. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
[TBL] [Abstract][Full Text] [Related]
7. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
[TBL] [Abstract][Full Text] [Related]
8. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
Lu F; Hou YQ; Song Y; Yuan ZJ
Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomic and phosphoproteomic studies reveal novel 5-fluorouracil resistant targets in hepatocellular carcinoma.
Liu Z; Wang Y; Yao Y; Fang Z; Miao QR; Ye M
J Proteomics; 2019 Sep; 208():103501. PubMed ID: 31454556
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics].
Gu W; Zhang YN; Li B; Han J; Cheng BB; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):265-70. PubMed ID: 16696913
[TBL] [Abstract][Full Text] [Related]
12. Identification of genes conferring resistance to 5-fluorouracil.
Yoo BK; Gredler R; Vozhilla N; Su ZZ; Chen D; Forcier T; Shah K; Saxena U; Hansen U; Fisher PB; Sarkar D
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12938-43. PubMed ID: 19622726
[TBL] [Abstract][Full Text] [Related]
13. Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells.
Zhang W; Feng M; Zheng G; Chen Y; Wang X; Pen B; Yin J; Yu Y; He Z
Biochem Biophys Res Commun; 2012 Jan; 417(2):679-85. PubMed ID: 22166209
[TBL] [Abstract][Full Text] [Related]
14. RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways.
Liu T; Wu X; Li Y; Lu W; Zheng F; Zhang C; Long Q; Qiu H; Li Y; Ge Q; Chen M; Yu X; Chen W; Zhang H; Huang W; Luo M; Deng W; Li L
Cell Physiol Biochem; 2018; 46(4):1365-1380. PubMed ID: 29689552
[TBL] [Abstract][Full Text] [Related]
15. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
[TBL] [Abstract][Full Text] [Related]
16. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NOTCH signaling pathway chemosensitizes HCC CD133
Hemati H; Kaur J; Sobti RC; Trehanpati N
Biochem Biophys Res Commun; 2020 May; 525(4):941-947. PubMed ID: 32173531
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression.
Ma K; He Y; Zhang H; Fei Q; Niu D; Wang D; Ding X; Xu H; Chen X; Zhu J
J Biol Chem; 2012 Feb; 287(8):5639-49. PubMed ID: 22117060
[TBL] [Abstract][Full Text] [Related]
19. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
[TBL] [Abstract][Full Text] [Related]
20. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
